Teacher Retirement System of Texas bought a new stake in shares of RadNet, Inc. (NASDAQ:RDNT – Free Report) in the 1st quarter, according to its most recent filing with the Securities & Exchange Commission. The fund bought 9,198 shares of the medical research company’s stock, valued at approximately $457,000.
Several other hedge funds have also bought and sold shares of RDNT. GAMMA Investing LLC lifted its holdings in shares of RadNet by 22.3% in the 1st quarter. GAMMA Investing LLC now owns 1,644 shares of the medical research company’s stock worth $82,000 after acquiring an additional 300 shares during the last quarter. Tower Research Capital LLC TRC raised its holdings in RadNet by 42.2% during the 4th quarter. Tower Research Capital LLC TRC now owns 1,422 shares of the medical research company’s stock valued at $99,000 after buying an additional 422 shares during the last quarter. Canada Pension Plan Investment Board bought a new stake in RadNet during the 4th quarter valued at $105,000. Twin Tree Management LP bought a new stake in RadNet during the 4th quarter valued at $106,000. Finally, Aquatic Capital Management LLC bought a new stake in RadNet during the 4th quarter valued at $187,000. 77.90% of the stock is currently owned by institutional investors.
RadNet Stock Performance
Shares of RDNT stock opened at $58.84 on Friday. RadNet, Inc. has a one year low of $45.00 and a one year high of $93.65. The company’s 50-day moving average is $57.26 and its 200 day moving average is $57.14. The company has a market capitalization of $4.41 billion, a price-to-earnings ratio of -136.83 and a beta of 1.41. The company has a debt-to-equity ratio of 0.87, a quick ratio of 2.01 and a current ratio of 2.01.
Insider Activity
Analysts Set New Price Targets
A number of research analysts have issued reports on RDNT shares. B. Riley started coverage on shares of RadNet in a research report on Friday, June 13th. They set a “buy” rating and a $69.00 price objective on the stock. Wall Street Zen downgraded shares of RadNet from a “hold” rating to a “sell” rating in a research report on Sunday, June 29th. Barclays reduced their price objective on shares of RadNet from $74.00 to $60.00 and set an “overweight” rating on the stock in a research report on Monday, March 24th. Finally, Truist Financial set a $74.00 target price on shares of RadNet in a research report on Thursday, July 10th. One investment analyst has rated the stock with a sell rating, three have issued a buy rating and three have assigned a strong buy rating to the company’s stock. According to MarketBeat.com, the stock presently has an average rating of “Buy” and a consensus target price of $69.60.
Read Our Latest Stock Report on RadNet
RadNet Profile
RadNet, Inc, together with its subsidiaries, provides outpatient diagnostic imaging services in the United States. The company operates in two segments: Imaging Centers and Artificial Intelligence. Its services include magnetic resonance imaging, computed tomography, positron emission tomography, nuclear medicine, mammography, ultrasound, diagnostic radiology, fluoroscopy, and other related procedures, as well as multi-modality imaging services.
Read More
- Five stocks we like better than RadNet
- REIT Stocks – Best REIT Stocks to Add to Your Portfolio Today
- The Market Rally Is Gaining Momentum—Don’t Get Left Behind
- How to start investing in penny stocks
- High-Flying GE Aerospace Drops After Blowout Q2 — What Now?
- Financial Services Stocks Investing
- Why Prologis May Be the Smartest Backdoor Bet on AI Real Estate
Receive News & Ratings for RadNet Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for RadNet and related companies with MarketBeat.com's FREE daily email newsletter.